ReviewFrontiers in pharmacology2016

P53-MDM2 Pathway: Evidences for A New Targeted Therapeutic Approach in B-Acute Lymphoblastic Leukemia.

Stefania Trino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.